简介：
Overview
This article presents a detailed protocol for the BioMILD screening trial aimed at detecting early lung cancer through a circulating microRNA signature classifier test. The method focuses on measuring plasma levels of specific microRNAs to assess lung cancer risk in heavy smokers over 50 years old.
Key Study Components
Area of Science
- Oncology
- Molecular Biology
- Biomarkers
Background
- MicroRNAs are indicators of the tumor microenvironment and host response.
- Early detection of lung cancer can significantly improve patient outcomes.
- The study aims to enhance the cost-effectiveness of lung cancer screening programs.
- Standard laboratory equipment can be used for microRNA measurement.
Purpose of Study
- To develop a reliable method for early lung cancer detection.
- To reduce false positives in lung cancer screening.
- To assess the risk of lung cancer in a high-risk population.
Methods Used
- Collection of plasma samples from participants using Vacutainer tubes.
- Isolation of RNA from plasma and conversion to cDNA.
- Use of real-time PCR to measure levels of specific microRNAs.
- Implementation of quality control measures to ensure data reliability.
Main Results
- The method allows simultaneous analysis of eight samples.
- MicroRNA signatures can classify risk levels for lung cancer.
- Over 10,000 samples have been tested in the BioMed Lancaster Screening Trial.
- The technique can be completed in approximately ten hours.
Conclusions
- The microRNA signature classifier shows promise for lung cancer diagnosis.
- Potential to improve diagnostic consistency and reduce screening costs.
- Further validation is needed to establish clinical utility.
What is the main goal of the study?
The main goal is to develop a method for early lung cancer detection using circulating microRNA levels.
How many samples can be analyzed simultaneously?
The method allows for the simultaneous analysis of eight samples.
What population is targeted for this screening?
The screening targets heavy smokers older than 50 years.
What are the advantages of this microRNA measurement technique?
It is cost-effective, easy to implement with standard equipment, and reduces false positives.
How long does the entire process take?
The technique can be completed in approximately ten hours.
What is the significance of the microRNA signatures?
They help classify the risk levels for lung cancer, aiding in diagnosis.
繁體中文
